C19orf66 Inhibitors
C19orf66, encoded by the C19orf66 gene located on chromosome 19, is a protein whose specific functions are not yet thoroughly elucidated. However, like many proteins whose roles have yet to be defined, the study of C19orf66 is significant for a comprehensive understanding of cellular and molecular processes. Proteins like C19orf66, despite their ambiguity, might be involved in specific cellular pathways, protein-protein interactions, or other cellular functions, making them subjects of interest in the realm of molecular biology and biochemistry. The presence of such proteins in various tissues or their differential expression under specific conditions might hint at their importance.
Inhibitors specific to C19orf66 would be molecules designed to reduce or completely halt the activity of the C19orf66 protein. By inhibiting its activity, scientists can observe the resultant cellular or physiological changes, giving clues about the protein's role. C19orf66 inhibitors would bind to the protein, thereby modulating its function or preventing it from participating in its typical cellular interactions. Studying the effects of these inhibitors can shed light on the broader context within which C19orf66 operates and can contribute to the understanding of any associated cellular pathways or processes in which this protein might play a role. The identification and study of such inhibitors are foundational in piecing together the puzzle of intricate cellular mechanisms and understanding the multifaceted nature of cellular biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D binds DNA and interferes with RNA synthesis. Its ability to inhibit transcription might lead to reduced synthesis of C19orf66 mRNA and consequently its protein. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin intercalates into DNA, preventingblockingthe transcription process. This mechanism might reduce C19orf66 mRNA synthesis, leading to decreased protein expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
As an antimetabolite, Fluorouracil can inhibit thymidylate synthase, leading to decreased DNA synthesis. This could result in an indirect reduction in C19orf66 gene expression. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, affecting DNA synthesis. The reduction in available nucleotides might indirectly reduce C19orf66 mRNA synthesis. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
By binding selectively to GC-rich DNA regions, Mithramycin A can prevent protein binding, potentially suppressing the transcription of genes, including C19orf66. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
As an HDAC inhibitor, Trichostatin A can modify chromatin structure and reduce the accessibility of transcriptional machinery to certain genes, potentially leading to reduced C19orf66 expression. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
By inhibiting the TGF-beta receptor, SB431542 influences various cellular pathways. If C19orf66 is part of the TGF-beta pathway, its expression might be reduced in the presence of this inhibitor. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As a JNK inhibitor, SP600125 can impact various cellular pathways. If C19orf66 expression is influenced by JNK, this compound might lead to its reduced expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 inhibits MEK, a part of the MAPK pathway. If C19orf66 is downstream of this pathway, its expression might be reduced by PD98059. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Inhibiting Rho-associated protein kinase (ROCK) with Y-27632 might alter various cellular pathways. If C19orf66 is influenced by ROCK signaling, its expression might be reduced. | ||||||